Page last updated: 2024-08-21

thiazoles and Bronze Diabetes

thiazoles has been researched along with Bronze Diabetes in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	2 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Economides, C; Eracleous, E; Kolnagou, A; Kontoghiorghes, GJ	1
Kontoghiorghes, GJ	1
Mathies, RA; Sensabaugh, GF; Woolley, AT	1

Reviews

2 review(s) available for thiazoles and Bronze Diabetes

Article	Year
Advances in iron overload therapies. prospects for effective use of deferiprone (L1), deferoxamine, the new experimental chelators ICL670, GT56-252, L1NA11 and their combinations. Current medicinal chemistry, 2005, Volume: 12, Issue:23 Topics: Benzoates; Carboxylic Acids; Deferasirox; Deferiprone; Deferoxamine; Drug Therapy, Combination; Hemochromatosis; Humans; Iron Chelating Agents; Iron Overload; Pyridones; Siderophores; Thalassemia; Thiazoles; Triazoles	2005
Future chelation monotherapy and combination therapy strategies in thalassemia and other conditions. comparison of deferiprone, deferoxamine, ICL670, GT56-252, L1NAll and starch deferoxamine polymers. Hemoglobin, 2006, Volume: 30, Issue:2 Topics: Benzoates; Carboxylic Acids; Chelation Therapy; Clinical Trials as Topic; Deferasirox; Deferiprone; Deferoxamine; Drug Evaluation; Drug Therapy, Combination; Forecasting; Hemochromatosis; Humans; Hydroxyethyl Starch Derivatives; Iron Chelating Agents; Iron Overload; Molecular Structure; Pyridones; Starch; Thalassemia; Thiazoles; Transfusion Reaction; Triazoles	2006

Article

Year

Advances in iron overload therapies. prospects for effective use of deferiprone (L1), deferoxamine, the new experimental chelators ICL670, GT56-252, L1NA11 and their combinations.

Current medicinal chemistry, 2005, Volume: 12, Issue:23

Topics: Benzoates; Carboxylic Acids; Deferasirox; Deferiprone; Deferoxamine; Drug Therapy, Combination; Hemochromatosis; Humans; Iron Chelating Agents; Iron Overload; Pyridones; Siderophores; Thalassemia; Thiazoles; Triazoles

2005

Future chelation monotherapy and combination therapy strategies in thalassemia and other conditions. comparison of deferiprone, deferoxamine, ICL670, GT56-252, L1NAll and starch deferoxamine polymers.

Hemoglobin, 2006, Volume: 30, Issue:2

Topics: Benzoates; Carboxylic Acids; Chelation Therapy; Clinical Trials as Topic; Deferasirox; Deferiprone; Deferoxamine; Drug Evaluation; Drug Therapy, Combination; Forecasting; Hemochromatosis; Humans; Hydroxyethyl Starch Derivatives; Iron Chelating Agents; Iron Overload; Molecular Structure; Pyridones; Starch; Thalassemia; Thiazoles; Transfusion Reaction; Triazoles

2006

Other Studies

1 other study(ies) available for thiazoles and Bronze Diabetes

Article	Year
High-speed DNA genotyping using microfabricated capillary array electrophoresis chips. Analytical chemistry, 1997, Jun-01, Volume: 69, Issue:11 Topics: Benzothiazoles; DNA; DNA Fragmentation; Electrophoresis, Capillary; Fluorescent Dyes; Genotype; Hemochromatosis; Hemochromatosis Protein; Histocompatibility Antigens Class I; Histocompatibility Testing; HLA Antigens; Humans; Membrane Proteins; Molecular Sequence Data; Quinolines; Thiazoles	1997

Article

Year

High-speed DNA genotyping using microfabricated capillary array electrophoresis chips.

Analytical chemistry, 1997, Jun-01, Volume: 69, Issue:11

Topics: Benzothiazoles; DNA; DNA Fragmentation; Electrophoresis, Capillary; Fluorescent Dyes; Genotype; Hemochromatosis; Hemochromatosis Protein; Histocompatibility Antigens Class I; Histocompatibility Testing; HLA Antigens; Humans; Membrane Proteins; Molecular Sequence Data; Quinolines; Thiazoles

1997